Formulating for the Future of Transplant Patient Therapy

Transplant Support

Veloxis is a specialty pharmaceutical company committed to improving the lives of transplant patients. Our unique, patented delivery technology, MeltDose®, is designed to enhance the absorption and bioavailability of select orally administered drugs.

Veloxis is an international company with headquarters in Hørsholm, Denmark, and a fully owned subsidiary in Edison, New Jersey, USA.

Veloxis is committed to patient access and financial support for kidney transplant patients. Learn more about our prescription cost savings programs, click here Go to


Nov 17, 2016
Q3 Results Investor Call

Webcast Webcast

Conference call at 3:00 pm CET

Please dial in 5-10 minutes prior to the start time using the number / Conference ID below. 

UK: +44(0)20 3427 1903
US: +1212 444 0895
DK: +4532 71 16 59
Confirmation Code:  3090135

Stock Information